Multi-institutional phase II trial of single agent regorafenib in refr
- This topic has 0 replies, 1 voice, and was last updated 8 years, 3 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
Multi-institutional phase II trial of single agent regorafenib in refractory advanced biliary cancers.
http://abstracts.asco.org/173/AbstView_173_159881.html
Viewing 1 post (of 1 total)
- The forum ‘Clinical Trials’ is closed to new topics and replies.